13F

STOK STOKE THERAPEUTICS INC

2026Q1 · CUSIP 86150R107 · Sector: Healthcare & Biotech

Cooling · Breadth rolling over
Holders
196
Δ holders QoQ
+12
Breadth percentile
Top 25%
Whale holders
110
Δ whales
+12
Inst. holding value
$2.3B
New positions
43
Closed positions
31
Price momentum (1Q)
-6.6%
Put / Call
4/4

Breadth history (34 quarters)

2019Q3: Δ+5 · h=52 2019Q4: Δ+13 · h=65 2020Q1: Δ+3 · h=68 2020Q2: Δ+3 · h=71 2020Q3: Δ+17 · h=88 2020Q4: Δ+5 · h=93 2021Q1: Δ+14 · h=107 2021Q2: Δ-10 · h=97 2021Q3: Δ-8 · h=89 2021Q4: Δ+8 · h=97 2022Q1: Δ+1 · h=98 2022Q2: Δ-4 · h=94 2022Q3: Δ+11 · h=105 2022Q4: Δ+4 · h=109 2023Q1: Δ-11 · h=98 2023Q2: Δ+2 · h=100 2023Q3: Δ-2 · h=98 2023Q4: Δ-17 · h=81 2024Q1: Δ+22 · h=103 2024Q2: Δ+11 · h=114 2024Q3: Δ+5 · h=119 2024Q4: Δ+12 · h=131 2025Q1: Δ-3 · h=128 2025Q2: Δ+7 · h=135 2025Q3: Δ+16 · h=151 2025Q4: Δ+33 · h=184 2026Q1: Δ+12 · h=196 2019Q3: holders=52 2019Q4: holders=65 2020Q1: holders=68 2020Q2: holders=71 2020Q3: holders=88 2020Q4: holders=93 2021Q1: holders=107 2021Q2: holders=97 2021Q3: holders=89 2021Q4: holders=97 2022Q1: holders=98 2022Q2: holders=94 2022Q3: holders=105 2022Q4: holders=109 2023Q1: holders=98 2023Q2: holders=100 2023Q3: holders=98 2023Q4: holders=81 2024Q1: holders=103 2024Q2: holders=114 2024Q3: holders=119 2024Q4: holders=131 2025Q1: holders=128 2025Q2: holders=135 2025Q3: holders=151 2025Q4: holders=184 2026Q1: holders=196 -33 -16.5 +0 +16.5 +33 46126206 19Q320Q221Q121Q422Q323Q224Q124Q425Q326Q1 Δ holders (bar) Holders (line)

Past Lit Events & Aftermath 5 lit events

Period Percentile Next-1Q return Next-2Q return
2025Q4 Top 16% -6.6%
2024Q1 Top 13% +6.8% -13.5%
2022Q3 Top 12% +1.9% +24.4%
2020Q3 Top 15% +31.0% -22.0%
2020Q1 Top 19% +3.9% +62.8%

Options Sentiment

Put holders
4
QoQ: +1
Call holders
4
QoQ: -2

See methodology →

Fundamentals

PE (TTM)
EPS (TTM)
$-2.81
EPS YoY
-442.7%
Revenue (TTM)
$0.0B
Revenue YoY
-83.2%
Quarterly Revenue & EPS (4Y)
2022-06-30: $3M 2022-09-30: $3M 2022-12-31: $3M 2023-03-31: $5M 2023-06-30: $-2M 2023-09-30: $3M 2023-12-31: $3M 2024-03-31: $4M 2024-06-30: $5M 2024-09-30: $5M 2024-12-31: $23M 2025-03-31: $159M 2025-06-30: $14M 2025-09-30: $11M 2025-12-31: $1M 2026-03-31: $6M 2022-06-30: EPS -0.63 2022-09-30: EPS -0.66 2022-12-31: EPS -0.65 2023-03-31: EPS -0.53 2023-06-30: EPS -0.69 2023-09-30: EPS -0.55 2023-12-31: EPS -0.61 2024-03-31: EPS -0.57 2024-06-30: EPS -0.46 2024-09-30: EPS -0.47 2024-12-31: EPS -0.15 2025-03-31: EPS 1.90 2025-06-30: EPS -0.40 2025-09-30: EPS -0.65 2025-12-31: EPS -0.97 2026-03-31: EPS -0.79 0M 79M 159M $M -1.07 0.51 2.09 20222023202420252026 Revenue EPS

Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable

P/E (TTM) over time
4Y median 21 2025-03-31: PE 11.92025-06-30: PE 20.72025-09-30: PE 37.9 11 25 40 20222023202420252026

P/E = close 47 days after quarter-end (filing date) ÷ TTM EPS then; loss quarters hidden

As of 2026-03-31 · SEC filings (XBRL)